title: Reversible sensorineural hearing loss in a girl with Kawasaki disease.
abstract: Kawasaki disease is an acute, self-limited vasculitis of infants and children that is now the most common cause of acquired heart disease in the pediatric age group in the United States and Japan. This report presents a case of classic Kawasaki disease with reversible sensorineural hearing loss that was treated with steroid. In conclusion, Kawasaki disease caregivers must be aware of possible sensorineural hearing loss, which is reversible by early intervention and thus improves quality of life.
authors.affiliation: Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
authors.forename: Ateş
authors.initials: A
authors.lastname: Kara
authors.forename: Nesrin
authors.initials: N
authors.lastname: Beşbaş
authors.forename: Hasan
authors.initials: H
authors.lastname: Tezer
authors.forename: Tevfik
authors.initials: T
authors.lastname: Karagöz
authors.forename: Ilker
authors.initials: I
authors.lastname: Devrim
authors.forename: Omer Faruk
authors.initials: OF
authors.lastname: Unal
mesh_terms: D001301:Audiometry, Pure-Tone; D001621:Betahistine / Q000627:therapeutic use; D002648:Child; D003911:Dextrans / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D042241:Early Diagnosis; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D017442:Histamine Agonists / Q000627:therapeutic use; D006801:Humans; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications* / Q000175:diagnosis; D011239:Prednisolone / Q000627:therapeutic use*
chemical_list: D003911:Dextrans; D005938:Glucocorticoids; D017442:Histamine Agonists; D011239:Prednisolone; D001621:Betahistine